SCOPUS: er.jErratum of the Eur J Clin Pharmacol 47 :477-481(http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/183860)info:eu-repo/semantics/publishe
Following publication of the original article [1], the authors reported an error in the name of the ...
This is a correction to: Clinical Kidney Journal, Volume 14, Issue 1, January 2021, Pages 226–236, h...
<p>Correction: Blood Pressure Control with a Single-Pill Combination of Indapamide Sustained-Release...
Hypertension is a major modifiable risk for the development of cardiovascular, cerebrovascular and r...
To study patient compliance in hypertensive outpatients amlodipine (5 mg once daily) and slow releas...
Prevalence and control of hypertension by 48-h ambulatory blood pressure monitoring in haemodialysis...
Patient compliance with therapy is often poor and overestimated by the treating physician; it is par...
Despite good pharmacologic control of blood pressure (BP), the untoward effects of noncompliance and...
Patient compliance with therapy is often poor and overestimated by the treating physician; it is par...
In the original publication, the funding statement was incorrectly published and the Editorial Assis...
compliance with pharmacist’s intervention based on cancer chemotherapy regimens: a cohort study Mako...
The authors would like to draw the readers' attention to an error in the following article: Negrini ...
Background and Objectives：Amlodipine camsylate (AmodipinTM), a newly developed amlodipine formulatio...
Patient compliance with therapy is often poor and overestimated by the treating physician; it is par...
<p>Unfortunately the original version of the article had the following two errors.</p
Following publication of the original article [1], the authors reported an error in the name of the ...
This is a correction to: Clinical Kidney Journal, Volume 14, Issue 1, January 2021, Pages 226–236, h...
<p>Correction: Blood Pressure Control with a Single-Pill Combination of Indapamide Sustained-Release...
Hypertension is a major modifiable risk for the development of cardiovascular, cerebrovascular and r...
To study patient compliance in hypertensive outpatients amlodipine (5 mg once daily) and slow releas...
Prevalence and control of hypertension by 48-h ambulatory blood pressure monitoring in haemodialysis...
Patient compliance with therapy is often poor and overestimated by the treating physician; it is par...
Despite good pharmacologic control of blood pressure (BP), the untoward effects of noncompliance and...
Patient compliance with therapy is often poor and overestimated by the treating physician; it is par...
In the original publication, the funding statement was incorrectly published and the Editorial Assis...
compliance with pharmacist’s intervention based on cancer chemotherapy regimens: a cohort study Mako...
The authors would like to draw the readers' attention to an error in the following article: Negrini ...
Background and Objectives：Amlodipine camsylate (AmodipinTM), a newly developed amlodipine formulatio...
Patient compliance with therapy is often poor and overestimated by the treating physician; it is par...
<p>Unfortunately the original version of the article had the following two errors.</p
Following publication of the original article [1], the authors reported an error in the name of the ...
This is a correction to: Clinical Kidney Journal, Volume 14, Issue 1, January 2021, Pages 226–236, h...
<p>Correction: Blood Pressure Control with a Single-Pill Combination of Indapamide Sustained-Release...
DOI
Add to ORKG